Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of NKTR-118 in patients with
impaired hepatic function versus subjects with normal hepatic function.